WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Panacos’ President and COO, Graham P. Allaway, Ph.D., made a plenary presentation on bevirimat (PA-457) at the 10th International Meeting of the Institute of Human Virology (IHV) in Baltimore, MD on November 17, 2006.
